A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye.
https://ift.tt/3tCU8zs
from WebMD Health https://ift.tt/2RSQmE3
by
A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye.
Comments
Post a Comment